Pixium Vision - Termination of coverage
Edison Investment Research is terminating coverage on Kinarus Therapeutics (KNRS), Numis Corporation (NUM), EMIS Group (EMIS), Pixium Vision (PIX)...
265 Views
Pixium Vision - Safeguard proceedings underway
Pixium Vision announced that safeguard proceedings have been opened by the Commercial Court of Paris. Despite the company’s best efforts in seeking...
212 Views
Pixium Vision - Shareholder loan extends runway
Pixium Vision recently announced that it has received a €3m bridge financing loan from shareholders Sofinnova (€1m) and Bpifrance (€2m), which...
322 Views
Pixium Vision - Focusing on reaching the PRIMAvera milestone
Having completed the required 38 implantations in late 2022, Pixium Vision’s key upcoming clinical milestone is the primary efficacy data, expected...
158 Views
Pixium Vision - Breakthrough designation provides validation
The US Food and Drug Administration (FDA) has granted Breakthrough Device designation (BDD) to Pixium’s wireless Prima bionic vision system (BVS),...
398 Views